Your browser doesn't support javascript.
loading
Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase.
Boddu, Prajwal C; Gupta, Abhishek K; Kim, Jung-Sik; Neugebauer, Karla M; Waldman, Todd; Pillai, Manoj M.
Afiliação
  • Boddu PC; Section of Hematology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
  • Gupta AK; Section of Hematology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA.
  • Kim JS; Department of Oncology, Molecular Biology and Genetics, Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
  • Neugebauer KM; Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT, USA.
  • Waldman T; Department of Oncology, Molecular Biology and Genetics, Lombardi Cancer Center, Georgetown University, Washington, DC, USA.
  • Pillai MM; Section of Hematology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA. manoj.pillai@yale.edu.
Commun Biol ; 4(1): 1184, 2021 10 13.
Article em En | MEDLINE | ID: mdl-34645977
ABSTRACT
Scalable isogenic models of cancer-associated mutations are critical to studying dysregulated gene function. Nonsynonymous mutations of splicing factors, which typically affect one allele, are common in many cancers, but paradoxically confer growth disadvantage to cell lines, making their generation and expansion challenging. Here, we combine AAV-intron trap, CRISPR/Cas9, and inducible Cre-recombinase systems to achieve >90% efficiency to introduce the oncogenic K700E mutation in SF3B1, a splicing factor commonly mutated in multiple cancers. The intron-trap design of AAV vector limits editing to one allele. CRISPR/Cas9-induced double stranded DNA breaks direct homologous recombination to the desired genomic locus. Inducible Cre-recombinase allows for the expansion of cells prior to loxp excision and expression of the mutant allele.  Importantly, AAV or CRISPR/Cas9 alone results in much lower editing efficiency and the edited cells do not expand due to toxicity of SF3B1-K700E. Our approach can be readily adapted to generate scalable isogenic systems where mutant oncogenes confer a growth disadvantage.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Íntrons / Integrases / Sistemas CRISPR-Cas / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Commun Biol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Íntrons / Integrases / Sistemas CRISPR-Cas / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Commun Biol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
...